Conjugates of folate anti-effector cell antibodies

David M Kranz (Inventor), Todd A Patrick (Inventor), Edward J Roy (Inventor)

Research output: Patent

Abstract

The present invention provides a process of targeting folate-receptor-positive tumor cells for lysis by binding a conjugate of folate and an anti-T-cell-receptor antibody or an anti-Fc receptor antibody to those cells. A process of lysing folate-receptor-positive tumor cells comprising exposing the cells to a folate/anti-T-cell-receptor antibody in the presence of a population of T-cells is also provided. A process of lysing folate-receptor-positive tumor cells comprising exposing the cells to a folate/anti-Fc receptor antibody in the presence of a population of natural killer cells, monocytes, or macrophages is also provided. Still further, the present invention provides a conjugate of folate to an anti-T-cell-receptor antibody or an anti-Fc receptor antibody.
Original languageEnglish (US)
U.S. patent number5547668
StatePublished - Aug 20 1996

Fingerprint

Dive into the research topics of 'Conjugates of folate anti-effector cell antibodies'. Together they form a unique fingerprint.

Cite this